Thermo Fisher Scientific Inc. (NYSE:TMO) shares saw an uptick in trading volume on Thursday . 1,257,031 shares changed hands during mid-day trading, an increase of 11% from the previous session’s volume of 1,134,402 shares.The stock last traded at $152.98 and had previously closed at $154.67.

A number of research firms recently weighed in on TMO. Zacks Investment Research lowered Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research report on Friday, August 5th. Jefferies Group restated a “hold” rating on shares of Thermo Fisher Scientific in a research report on Thursday, August 4th. Citigroup Inc. raised their price objective on Thermo Fisher Scientific from $160.00 to $182.00 and gave the stock a “buy” rating in a research report on Friday, July 29th. Mizuho set a $175.00 price objective on Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, July 28th. Finally, BTIG Research upgraded Thermo Fisher Scientific from a “neutral” rating to a “buy” rating and set a $180.00 price objective for the company in a research report on Friday, July 22nd. Two equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and an average target price of $159.66.

The company has a market cap of $60.46 billion and a price-to-earnings ratio of 30.68. The firm’s 50-day moving average price is $155.29 and its 200 day moving average price is $145.37.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings data on Thursday, July 28th. The company reported $2.03 EPS for the quarter, beating analysts’ consensus estimates of $2.01 by $0.02. The company earned $4.54 billion during the quarter, compared to the consensus estimate of $4.50 billion. The company’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.84 EPS. On average, analysts predict that Thermo Fisher Scientific Inc. will post $8.15 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, October 17th. Investors of record on Thursday, September 15th will be issued a $0.15 dividend. The ex-dividend date is Tuesday, September 13th. This represents a $0.60 dividend on an annualized basis and a yield of 0.39%.

In other Thermo Fisher Scientific news, Director C Martin Harris sold 390 shares of the stock in a transaction dated Friday, August 5th. The stock was sold at an average price of $157.33, for a total value of $61,358.70. Following the completion of the sale, the director now directly owns 4,648 shares in the company, valued at $731,269.84. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Peter M. Wilver sold 68,200 shares of the stock in a transaction dated Friday, June 10th. The stock was sold at an average price of $152.38, for a total value of $10,392,316.00. Following the completion of the sale, the vice president now owns 64,727 shares of the company’s stock, valued at $9,863,100.26. The disclosure for this sale can be found here.

Other large investors have made changes to their positions in the company. Argent Trust Co increased its stake in shares of Thermo Fisher Scientific by 0.8% in the third quarter. Argent Trust Co now owns 10,619 shares of the company’s stock valued at $1,299,000 after buying an additional 80 shares during the period. Utah Retirement Systems increased its stake in shares of Thermo Fisher Scientific by 0.3% in the fourth quarter. Utah Retirement Systems now owns 71,534 shares of the company’s stock valued at $10,147,000 after buying an additional 200 shares during the period. Advisors Asset Management Inc. increased its stake in shares of Thermo Fisher Scientific by 1.3% in the fourth quarter. Advisors Asset Management Inc. now owns 66,067 shares of the company’s stock valued at $9,372,000 after buying an additional 865 shares during the period. Mitsubishi UFJ Kokusai Asset Management CO. LTD. increased its stake in shares of Thermo Fisher Scientific by 6.2% in the fourth quarter. Mitsubishi UFJ Kokusai Asset Management CO. LTD. now owns 52,908 shares of the company’s stock valued at $7,505,000 after buying an additional 3,100 shares during the period. Finally, Suntrust Banks Inc. increased its stake in shares of Thermo Fisher Scientific by 7.9% in the fourth quarter. Suntrust Banks Inc. now owns 51,542 shares of the company’s stock valued at $7,309,000 after buying an additional 3,759 shares during the period.

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.